{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:33:51Z","timestamp":1769052831870,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bbi.2019.09.017","type":"journal-article","created":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T01:39:41Z","timestamp":1569202781000},"page":"288-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Chemokine CCR5 and cocaine interactions in the brain: Cocaine enhances mesolimbic CCR5 mRNA levels and produces place preference and locomotor activation that are reduced by a CCR5 antagonist"],"prefix":"10.1016","volume":"83","author":[{"given":"Sunil U.","family":"Nayak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Cicalese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Tallarida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chicora F.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M.","family":"Rawls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2019.09.017_b0005","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/adb.12156","article-title":"Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity","volume":"20","author":"Araos","year":"2015","journal-title":"Addict. Biol."},{"key":"10.1016\/j.bbi.2019.09.017_b0010","doi-asserted-by":"crossref","first-page":"21814","DOI":"10.1074\/jbc.271.36.21814","article-title":"Differential regulation of G-protein-mediated signaling by chemokine receptors","volume":"271","author":"Arai","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2019.09.017_b0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s13365-010-0004-3","article-title":"Neurotrophins modulate the expression of chemokine receptors in the brain","volume":"17","author":"Avdoshina","year":"2011","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.bbi.2019.09.017_b0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugalcdep.2017.08.003","article-title":"Glial and neuroinflammatory targets for treating substance use disorders","volume":"180","author":"Bachtell","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbi.2019.09.017_b0025","doi-asserted-by":"crossref","unstructured":"Basova, L., Najera, J.A., Bortell, N., Wang, D., Moya, R., Lindsey, A., Semenova, S., Ellis, R.J., Marcondes, M.C.G., 2018. Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to methamphetamine.","DOI":"10.1371\/journal.pone.0199861"},{"key":"10.1016\/j.bbi.2019.09.017_b0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.nbd.2012.08.001","article-title":"Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration","volume":"49","author":"Choi","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"15","key":"10.1016\/j.bbi.2019.09.017_b9000","doi-asserted-by":"crossref","first-page":"9542","DOI":"10.1074\/jbc.M114.596098","article-title":"Biased signaling at chemokine receptors","volume":"290","author":"Corbisier","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2019.09.017_b0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nbd.2018.05.017","article-title":"Cocaine-mediated activation of microglia and microglial MeCP2 and BDNF production","volume":"117","author":"Cotto","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2019.09.017_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-801284-0.00001-4","article-title":"Chapter one-neuroimmune mechanisms of alcohol and drug addiction","volume":"118","author":"Cui","year":"2014","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.bbi.2019.09.017_b0045","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/AAC.49.11.4721-4732.2005","volume":"49","author":"Dorr","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbi.2019.09.017_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108232","article-title":"Dopamine receptor activation increases HIV entry into primary human macrophages","volume":"9","author":"Gaskill","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2019.09.017_b0055","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/bph.12951","article-title":"Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats","volume":"172","author":"Gregg","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2019.09.017_b0060","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.neuroscience.2009.05.048","article-title":"Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release","volume":"162","author":"Guyon","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2019.09.017_b0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fncel.2014.00065","article-title":"CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems","volume":"8","author":"Guyon","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbi.2019.09.017_b0070","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acschemneuro.7b00510","article-title":"Dopamine D1-like receptor agonist and D2-like receptor antagonist (-)-stepholidine reduces reinstatement of drug-seeking behavior for 3,4-methylenedioxypyrovalerone (MDPV) in rats","volume":"9","author":"Hicks","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbi.2019.09.017_b0080","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tips.2013.01.004","article-title":"What's conditioned in conditioned place preference?","volume":"34","author":"Huston","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbi.2019.09.017_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.08.041","article-title":"Chemokines in the MPTP model of Parkinson\u2019s disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration","volume":"1128","author":"Kalkonde","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2019.09.017_b0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbi.2016.08.015","article-title":"Chemokines and cocaine: CXCR4 receptor antagonist AMD3100 attenuates cocaine place preference and locomotor stimulation in rats","volume":"62","author":"Kim","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.09.017_b0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fnana.2017.00137","article-title":"Glial- and neuronal-specific expression of CCL5 mRNA in the rat brain","volume":"11","author":"Lanfranco","year":"2018","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.bbi.2019.09.017_b0100","doi-asserted-by":"crossref","first-page":"14500","DOI":"10.1073\/pnas.95.24.14500","article-title":"Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity","volume":"95","author":"Meucci","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbi.2019.09.017_b0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.drugalcdep.2018.01.013","article-title":"Chemokines and 'Bath Salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats","volume":"186","author":"Oliver","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbi.2019.09.017_b0110","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1016\/S0006-3495(02)75307-1","article-title":"Structure modeling of the chemokine receptor CCR5: implications for ligand binding and selectivity","volume":"83","author":"Paterlini","year":"2002","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbi.2019.09.017_b0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuropharm.2016.06.024","article-title":"Ibudilast attenuates expression of behavioral sensitization to cocaine in male and female rats","volume":"109","author":"Poland","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2019.09.017_b0120","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1471-4159.2007.04639.x","article-title":"The chemokine stromal cell-derived factor-1\/CXCL12 activates the nigrostriatal dopamine system","volume":"102","author":"Skrzydelski","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2019.09.017_b0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2009.03.027","article-title":"Modulation of cocaine-induced activity by intracerebral administration of CXCL12","volume":"161","author":"Trecki","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2019.09.017_b0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12031-011-9508-4","article-title":"Implication of CCR2 chemokine receptor in cocaine-induced sensitization","volume":"44","author":"Trocello","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbi.2019.09.017_b0135","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1124\/dmd.104.002626","article-title":"Species differences in the disposition of the CCR5 antagonist, UK-427,857, a new potential treatment for HIV","volume":"33","author":"Walker","year":"2005","journal-title":"Drug Metab. Disposit."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915911930772X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915911930772X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:00:48Z","timestamp":1760169648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088915911930772X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":27,"alternative-id":["S088915911930772X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2019.09.017","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemokine CCR5 and cocaine interactions in the brain: Cocaine enhances mesolimbic CCR5 mRNA levels and produces place preference and locomotor activation that are reduced by a CCR5 antagonist","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2019.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}